Select Publications

Journal articles

Silverberg JI; Pinter A; Alavi A; Lynde C; Bouaziz JD; Wollenberg A; Murrell DF; Alpizar S; Laquer V; Chaouche K; Ahmad F; Armstrong JM; Piketty C, 2021, 'Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study', Journal of the European Academy of Dermatology and Venereology, 35, pp. 1562 - 1568, http://dx.doi.org/10.1111/jdv.17218

Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS, 2021, 'Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis', Journal of the American Academy of Dermatology, 85, pp. 1 - 14, http://dx.doi.org/10.1016/j.jaad.2020.11.076

Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN, 2021, 'Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy', Journal of the American Academy of Dermatology, 85, pp. 18 - 27, http://dx.doi.org/10.1016/j.jaad.2020.05.161

Kasperkiewicz M; Schmidt E; Amagai M; Fairley JA; Joly P; Murrell DF; Payne AS; Yale ML; Zillikens D; Woodley DT, 2021, 'Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic', Journal of the European Academy of Dermatology and Venereology, 35, pp. e412 - e414, http://dx.doi.org/10.1111/jdv.17207

Murrell DF; Paul CF, 2021, 'What instruments should we add to our toolbox for measuring the severity and control of eczema?', British Journal of Dermatology, 185, pp. 13 - 14, http://dx.doi.org/10.1111/bjd.20398

Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS, 2021, 'Intraepithelial autoimmune blistering dermatoses: Clinical features and diagnosis', Journal of the American Academy of Dermatology, 84, pp. 1507 - 1519, http://dx.doi.org/10.1016/j.jaad.2020.11.075

Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN, 2021, 'Intraepithelial autoimmune bullous dermatoses disease activity assessment and therapy', Journal of the American Academy of Dermatology, 84, pp. 1523 - 1537, http://dx.doi.org/10.1016/j.jaad.2021.02.073

Murrell DF; Murase JE, 2021, 'The International Reach of the International Journal of Women's Dermatology and the Women's Dermatologic Society', International Journal of Women's Dermatology, 7, pp. 235 - 236, http://dx.doi.org/10.1016/j.ijwd.2021.05.004

Ramirez-Quizon M; Murrell DF, 2021, 'Managing epidermolysis bullosa during the coronavirus pandemic: Experience and ideals', Clinics in Dermatology, 39, pp. 369 - 373, http://dx.doi.org/10.1016/j.clindermatol.2021.01.014

Lincoln V; Chao L; Woodley DT; Murrell D; Kim M; O'Toole EA; Ly A; Cogan J; Mosallaei D; Wysong A; Chen M, 2021, 'Over-expression of stromal periostin correlates with poor prognosis of cutaneous squamous cell carcinomas', Experimental Dermatology, 30, pp. 698 - 704, http://dx.doi.org/10.1111/exd.14281

Viti G; Forcella C; Feliciani C; Murrell DF, 2021, 'Beyond the skin: Disease parameters in pemphigus', Italian Journal of Dermatology and Venereology, 156, pp. 147 - 150, http://dx.doi.org/10.23736/S2784-8671.21.06678-5

Rogers CL; Gibson M; Kern JS; Martin LK; Robertson SJ; Daniel BS; Su JC; Murrell OGC; Feng G; Murrell DF, 2021, 'A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', JAAD International, 2, pp. 134 - 152, http://dx.doi.org/10.1016/j.jdin.2020.12.007

Murase JE; Murrell DF, 2021, 'Heralding change within dermatology: Response of the International Journal of Women's Dermatology (IJWD) to the twin pandemic of racism', International Journal of Women's Dermatology, 7, pp. 125 - 126, http://dx.doi.org/10.1016/j.ijwd.2021.03.008

Krueger JG; Murrell DF; Garcet S; Navrazhina K; Lee PC; Muscianisi E; Blauvelt A, 2021, 'Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis', Journal of Allergy and Clinical Immunology, 147, pp. 1107 - 1109.e2, http://dx.doi.org/10.1016/j.jaci.2020.09.021

Daniel BS; Murrell DF, 2021, 'The role of women as past and present advocates for vaccinations: Relevance in the COVID-19 setting', International Journal of Women's Dermatology, 7, pp. 228 - 229, http://dx.doi.org/10.1016/j.ijwd.2020.10.001

Murrell DF; Cheesborough J; Woodley DT, 2021, 'Obituary: Vale Robert Alan Briggaman MD 1934-2020', BRITISH JOURNAL OF DERMATOLOGY, 184, pp. 379 - 380, http://dx.doi.org/10.1111/bjd.19404

Shakshouk H; Daneshpazhooh M; Murrell DF; Lehman JS, 2021, 'Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”', Journal of the American Academy of Dermatology, 84, pp. e61 - e62, http://dx.doi.org/10.1016/j.jaad.2020.09.002

Barua DP; Chowdhury MIH; Mowla MR; Reich A; Murrell D; Ruzicka T, 2021, 'Comparison of effectiveness of topical tacrolimus 0.1% vs topical halobetasol propionate 0.05% as an add-on to oral hydroxychloroquine in discoid lupus erythematosus', Dermatologic Therapy, 34, http://dx.doi.org/10.1111/dth.14675

Sheriff T; Dickenson-Panas H; Murrell DF, 2021, 'Conducting dermatology clinical trials during the COVID-19 pandemic', Clinics in Dermatology, 39, pp. 104 - 106, http://dx.doi.org/10.1016/j.clindermatol.2020.12.019

Sabourirad S; Peera MR; Wilcsek G; Murrell DF, 2021, 'Ectropion surgery might not be a long-term solution for harlequin ichthyosis', Dermatologic Therapy, 34, http://dx.doi.org/10.1111/dth.14646

Rogers C; Gibson M; Kern JS; Martin LK; Robertson SJ; Su JC; Daniel BS; Murrell DF, 2021, '157 A comparison study of Outcome Measures for Epidermolysis Bullosa; Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', Journal of Investigative Dermatology, 141, pp. S28 - S28, http://dx.doi.org/10.1016/j.jid.2021.02.177

Wilson BN; Sun M; Olayinka J; Murrell DF; Murase J, 2021, '557 Assessment of skin of color and diversity and inclusion content published in the Journal of Investigative Dermatology: An analysis and call to action', Journal of Investigative Dermatology, 141, pp. S97 - S97, http://dx.doi.org/10.1016/j.jid.2021.02.584

Bruckner A; Kern JS; Sprecher E; Fernandez M; Cunningham T; Sumeray M; Murrell DF, 2021, '615 Efficacy and safety of Oleogel-S10 (birch triterpenes) for recessive dystrophic epidermolysis bullosa (RDEB): Results of 3 months double-blind treatment of the phase 3 study ‘EASE’', Journal of Investigative Dermatology, 141, pp. S107 - S107, http://dx.doi.org/10.1016/j.jid.2021.02.644

Sabourirad S; Murrell DF, 2021, 'A dark lesion on an Indian Woman's vulva', International Journal of Women's Dermatology, 7, pp. 201 - 202, http://dx.doi.org/10.1016/j.ijwd.2021.02.004

Bodemer C; Kern J; Sprecher E; Bruckner AL; Davis C; Cunningham T; Sumeray M; Murrell DF, 2021, 'Efficacité et innocuité de l’Oleogel-S10 (triterpènes de bouleau) dans l’épidermolyse bulleuse : résultats à 3 mois de l’étude de phase 3 « EASE » en double aveugle', Annales de Dermatologie et de Vénéréologie - FMC, 1, pp. A107 - A107, http://dx.doi.org/10.1016/j.fander.2021.09.525

Mazure CM; Williams ML, 2021, 'Introduction and purpose: The House of Medicine & Dermatology.', Int J Womens Dermatol, 7, pp. 517 - 518, http://dx.doi.org/10.1016/j.ijwd.2021.09.005

Kang M; Bilgic A; Radjenovic M; Murrell DF, 2020, 'Osteoporosis and bone health in autoimmune blistering skin disease—an evidenced based review', Journal of the European Academy of Dermatology and Venereology, 34, pp. 2745 - 2756, http://dx.doi.org/10.1111/jdv.16334

Goldman MP; Murrell DF; Al-Mutairi N; Arenbergerova M; Dréno B; Alhaddad M; Al-Suwaidan SN; Firooz A; van de Kerkhof PCM; Feldman SR, 2020, 'International collaboration', Journal of Dermatological Treatment, 31, pp. 757, http://dx.doi.org/10.1080/09546634.2020.1794290

Woodley DT; Murrell DF, 2020, 'A giant in dermatology has fallen: Robert Alan "Al'' Briggaman, MD IN MEMORY', JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 83, pp. E381 - E381, http://dx.doi.org/10.1016/j.jaad.2020.06.076

Schwartz RA; Pradhan S; Murrell DF; Jafferany M; Olisova OY; Lomonosov KM; Lotti T; Goldust M, 2020, 'COVID-19 and immunosuppressive therapy in dermatology', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.14140

Goldust M; Sharma A; Murrell DF; Kazemi N; Rudnicka L; Kassir M; Navarini A; Mueller SM, 2020, 'Dermatology and specialty rotations: COVID-19 may reemphasize the importance of internal medicine', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13996

Gorell ES; Wolstencroft PW; de Souza MP; Murrell DF; Linos E; Tang JY, 2020, 'Financial burden of epidermolysis bullosa on patients in the United States', Pediatric Dermatology, 37, pp. 1198 - 1201, http://dx.doi.org/10.1111/pde.14340

van Beek N; Krüger S; Fuhrmann T; Lemcke S; Goletz S; Probst C; Komorowski L; Di Zenzo G; Dmochowski M; Drenovska K; Horn M; Jedlickova H; Kowalewski C; Medenica L; Murrell D; Patsatsi A; Geller S; Uzun S; Vassileva S; Zhu X; Fechner K; Zillikens D; Stöcker W; Schmidt E; Rentzsch K, 2020, 'Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology', Journal of the American Academy of Dermatology, 83, pp. 1315 - 1322, http://dx.doi.org/10.1016/j.jaad.2020.01.049

Murrell DF; Kroumpouzos G; Gupta A; di Lernia V; Sadoughifar R; Goldust M, 2020, 'Role of music therapy in reducing the burden of dermatological diseases during COVID-19', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.14086

Ferries L; Gillibert A; Duvert-Lehembre S; Corbaux C; Alexandre M; Prost-Squarcioni C; Caux F; Delaporte E; Litrowski N; Boulard C; Murrell DF; Joly P; Hébert V, 2020, 'Sensitivity to change and correlation between the autoimmune bullous disease quality-of-life questionnaires ABQOL and TABQOL, and objective severity scores', British Journal of Dermatology, 183, pp. 944 - 945, http://dx.doi.org/10.1111/bjd.19173

Azimi SZ; Firooz A; Murrell DF; Daneshpazhooh M, 2020, 'Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13956

Has C; Bauer JW; Bodemer C; Bolling MC; Bruckner-Tuderman L; Diem A; Fine JD; Heagerty A; Hovnanian A; Marinkovich MP; Martinez AE; McGrath JA; Moss C; Murrell DF; Palisson F; Schwieger-Briel A; Sprecher E; Tamai K; Uitto J; Woodley DT; Zambruno G; Mellerio JE, 2020, 'Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility', British Journal of Dermatology, 183, pp. 614 - 627, http://dx.doi.org/10.1111/bjd.18921

Murrell DF; Lucky AW; Salas-Alanis JC; Woodley DT; Palisson F; Natsuga K; Nikolic M; Ramirez-Quizon M; Paller AS; Lara-Corrales I; Barzegar MA; Sprecher E; Has C; Laimer M; Bruckner AL; Bilgic A; Nanda A; Purvis D; Hovnanian A; Murat-Sušić S; Bauer J; Kern JS; Bodemer C; Martin LK; Mellerio J; Kowaleski C; Robertson SJ; Bruckner-Tuderman L; Pope E; Marinkovich MP; Tang JY; Su J; Uitto J; Eichenfield LF; Teng J; Aan Koh MJ; Lee SE; Khuu P; Rishel HI; Sommerlund M; Wiss K; Hsu CK; Chiu TW; Martinez AE, 2020, 'Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic—Consensus: Recommendations by an international panel of experts', Journal of the American Academy of Dermatology, 83, pp. 1222 - 1224, http://dx.doi.org/10.1016/j.jaad.2020.06.1023

Goodale EC; White SD; Bizikova P; Borjesson D; Murrell DF; Bisconte A; Francesco M; Hill RJ; Masjedizadeh M; Nunn P; Gourlay SG; Jordan TJM; Emery CB; Outerbridge CA, 2020, 'Open trial of Bruton’s tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus', Veterinary Dermatology, 31, pp. 410 - e110, http://dx.doi.org/10.1111/vde.12878

Teimourpour A; Hedayat K; Salarvand F; Ghandi N; Ghiasi M; Mahmoudi H; Balighi K; Toosi R; Mohebi F; Nili A; Daneshpazhooh M; Murrell DF; Chams-Davatchi C, 2020, 'Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: Validation of the translated Persian version in pemphigus vulgaris', International Journal of Women's Dermatology, 6, pp. 306 - 310, http://dx.doi.org/10.1016/j.ijwd.2020.03.043

Pope E; Mansour M; Berseneva M; Liy-Wong C; Salas J; Fuentes I; Yubero MJ; Palisson F; Martinez A; Mellerio J; Lara-Corrales I; Yang A; Murrell D; Torres-Pradilla M; Lucky A, 2020, 'Outcomes and Predictors for Re-stenosis of Esophageal Stricture in Epidermolysis Bullosa: A Multicenter Cohort Study', Journal of Pediatric Gastroenterology and Nutrition, 71, pp. 310 - 314, http://dx.doi.org/10.1097/MPG.0000000000002820

Murrell DF; Uitto J, 2020, 'Splicing of the cake can affect the severity of epidermolysis bullosa', Journal of the European Academy of Dermatology and Venereology, 34, pp. 1879 - 1880, http://dx.doi.org/10.1111/jdv.16859

Joly P; Horvath B; Patsatsi ; Uzun S; Bech R; Beissert S; Bergman R; Bernard P; Borradori L; Caproni M; Caux F; Cianchini G; Daneshpazhooh M; De D; Dmochowski M; Drenovska K; Ehrchen J; Feliciani C; Goebeler M; Groves R; Guenther C; Hofmann S; Ioannides D; Kowalewski C; Ludwig R; Lim YL; Marinovic B; Marzano AV; Mascaró JM; Mimouni D; Murrell DF; Pincelli C; Squarcioni CP; Sárdy M; Setterfield J; Sprecher E; Vassileva S; Wozniak K; Yayli S; Zambruno G; Zillikens D; Hertl M; Schmidt E, 2020, 'Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)', Journal of the European Academy of Dermatology and Venereology, 34, pp. 1900 - 1913, http://dx.doi.org/10.1111/jdv.16752

Goldust M; Kroumpouzos G; Murrell DF; Jafferany M; Lotti T; Wollina U; Shivakumar S, 2020, 'Use of face masks in dermatology department during the COVID-19 outbreak', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13521

Verheyden MJ; Bilgic A; Murrell DF, 2020, 'A systematic review of drug-associated bullous pemphigoid', Acta Dermato-Venereologica, 100, pp. 1 - 9, http://dx.doi.org/10.2340/00015555-3457

Goodale EC; Varjonen KE; Outerbridge CA; Bizikova P; Borjesson D; Murrell DF; Bisconte A; Francesco M; Hill RJ; Masjedizadeh M; Nunn P; Gourlay SG; White SD, 2020, 'Efficacy of a Bruton's Tyrosine Kinase Inhibitor (PRN-473) in the treatment of canine pemphigus foliaceus', Veterinary Dermatology, 31, pp. 291 - e71, http://dx.doi.org/10.1111/vde.12841

Murrell DF; Paller AS; Bodemer C; Browning J; Nikolic M; Barth JA; Lagast H; Krusinska E; Reha A, 2020, 'Wound closure in epidermolysis bullosa: data from the vehicle arm of the phase 3 ESSENCE Study', Orphanet Journal of Rare Diseases, 15, http://dx.doi.org/10.1186/s13023-020-01435-3

Murrell DF; Arora G; Rudnicka L; Kassir M; Lotti T; Goldust M, 2020, 'A dermatologist's perspective of the COVID-19 outbreak', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13538

Yang A; Cheung K; Kossard S; Murrell DF, 2020, 'Atypical Disseminated Variant of Galli-Galli Disease: A Review of the Literature', American Journal of Dermatopathology, 42, pp. 484 - 490, http://dx.doi.org/10.1097/DAD.0000000000001467

Sheriff T; Murrell OGC; Murrell DF, 2020, 'Restructuring an academic dermatology practice during the COVID-19 pandemic', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13684


Back to profile page